ResMed Inc. (NYSE: RMD) last traded at $235.44, up 2.34% on the session. The quote above updates while this page is open; the figures below are drawn from ResMed Inc.’s own filings and are restated only when a new one is published.
ResMed Inc. trades on NYSE under the ticker RMD. Its market capitalisation is $33.96 billion.
Valuation measures for ResMed Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $33.96B |
|---|---|
| Enterprise value | $34.87B |
| P/E ratio | 22.57 |
| Price / sales | 6.01 |
| Price / book | 5.16 |
| Beta | 0.38 |
Trailing-twelve-month figures tagged in ResMed Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $5.65B |
|---|---|
| Net income (TTM) | $1.52B |
| EPS (TTM) | $10.43 |
| Gross margin | 61.06% |
| Operating margin | 33.37% |
| Return on equity | 23.13% |
| Cash | $1.47B |
Range and volume for RMD over the past 52 weeks.
| 52-week high | $277.67 |
|---|---|
| 52-week low | $180.27 |
| Volume | 421.5K |
| Average volume | 1.31M |
| Previous close | $230.05 |
Dividend history for ResMed Inc. over the trailing twelve months.
| Dividend yield | 1.02% |
|---|---|
| Dividend per share (TTM) | $2.40 |
| Payout ratio | 23.01% |
Invest a chosen dollar amount in ResMed Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RMD.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.